Chargement en cours...
Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
Isocitrate dehydrogenase (IDH) is a key rate-limiting enzyme in the Krebs cycle that plays an important role in energy metabolism. In recent years, it has been found that IDH mutations are closely related to the occurrence and development of glioma, and it is a notable potential therapeutic target....
Enregistré dans:
| Publié dans: | Front Oncol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584818/ https://ncbi.nlm.nih.gov/pubmed/31263678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00506 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|